← Back to graph

Prescription

methylphenidate chewable Quillivant XR liquid

Selected indexed studies

New Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and Tolerability. (CNS Drugs, 2017) [PMID:28130762]

_Worker-drafted node — pending editorial review._

Connections

No connections recorded yet.

Sources

New Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and Tolerability. (2017) pubmed

Local graph